In the first part in a new series of podcasts with Healio, we explore the pharma industry’s issues with programmatic advertising. Zach Gursky, SVP, Digital and Innovation at Healio walks us through the issues that have made some pharma marketers reluctant to fully embrace programmatic buying and explains whether there really is any need to be concerned.
Originally published by PM360
OTHER RESOURCES & INSIGHTS
Peruse our collection of resources designed to help you increase specialty HCP engagement.
Your success is what drives us. Together, we can advance healthcare. Contact us to get started.